Source:http://linkedlifedata.com/resource/pubmed/id/16130745
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005767,
umls-concept:C0008565,
umls-concept:C0010194,
umls-concept:C0028040,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0185125,
umls-concept:C0201734,
umls-concept:C0206056,
umls-concept:C0459385,
umls-concept:C0521115,
umls-concept:C0680730,
umls-concept:C0870883,
umls-concept:C1148554,
umls-concept:C1948027
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2005-8-31
|
pubmed:abstractText |
To elucidate the disposition of nicotine in the brain is important because the neuropharmacological effects from nicotine exposure are centrally predominated. The aim of the present study was to develop a rapid and simple method for the simultaneous determination of unbound nicotine and its main metabolite, cotinine, in rat blood and brain tissue. We coupled a multiple sites microdialysis sampling technique with HPLC-UV system to characterize the pharmacokinetics of both nicotine and cotinine. Microdialysis probes were inserted into the jugular vein/right atrium and brain striatum of Sprague-Dawley rats, and nicotine (2 mg/kg, i.v.) was administered via the femoral vein. Dialysates were collected every 10 min and injected directly into a HPLC system. Both nicotine and cotinine were separated by a phenyl-hexyl column (150 mm x 4.6 mm) from dialysates within 12 min. The mobile phase consisted of an acetonitrile-methanol-20 mM monosodium phosphate buffer (55:45:900, v/v/v, pH adjusted to 5.1) with a flow-rate of 1 ml/min. The wavelength of the UV detector was set at 260 nm. The limit of quantification for nicotine and cotinine were 0.25 microg/ml and 0.05 microg/ml, respectively. Intra- and inter-day precision and accuracy of both measurements fell well within the predefined limits of acceptability. The blood and brain concentration-time profile of nicotine and cotinine suggests that nicotine is easily to get into the central nervous system and cotinine exhibits a long retention time and accumulates in blood.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0021-9673
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
1088
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
152-7
|
pubmed:dateRevised |
2009-1-15
|
pubmed:meshHeading |
pubmed-meshheading:16130745-Animals,
pubmed-meshheading:16130745-Brain,
pubmed-meshheading:16130745-Chromatography, High Pressure Liquid,
pubmed-meshheading:16130745-Cotinine,
pubmed-meshheading:16130745-Microdialysis,
pubmed-meshheading:16130745-Nicotine,
pubmed-meshheading:16130745-Rats,
pubmed-meshheading:16130745-Reproducibility of Results,
pubmed-meshheading:16130745-Sensitivity and Specificity,
pubmed-meshheading:16130745-Spectrophotometry, Ultraviolet
|
pubmed:year |
2005
|
pubmed:articleTitle |
Simultaneous determination of nicotine and its metabolite, cotinine, in rat blood and brain tissue using microdialysis coupled with liquid chromatography: pharmacokinetic application.
|
pubmed:affiliation |
Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|